HK1016188A1 - Steroid compounds having contraceptive and antiosteoporosis activity - Google Patents

Steroid compounds having contraceptive and antiosteoporosis activity

Info

Publication number
HK1016188A1
HK1016188A1 HK99101306A HK99101306A HK1016188A1 HK 1016188 A1 HK1016188 A1 HK 1016188A1 HK 99101306 A HK99101306 A HK 99101306A HK 99101306 A HK99101306 A HK 99101306A HK 1016188 A1 HK1016188 A1 HK 1016188A1
Authority
HK
Hong Kong
Prior art keywords
contraceptive
steroid compounds
antiosteoporosis
activity
antiosteoporosis activity
Prior art date
Application number
HK99101306A
Other languages
English (en)
Inventor
H J J Loozen
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of HK1016188A1 publication Critical patent/HK1016188A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0085—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK99101306A 1997-02-21 1999-03-30 Steroid compounds having contraceptive and antiosteoporosis activity HK1016188A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97102884 1997-02-21

Publications (1)

Publication Number Publication Date
HK1016188A1 true HK1016188A1 (en) 1999-10-29

Family

ID=8226513

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99101306A HK1016188A1 (en) 1997-02-21 1999-03-30 Steroid compounds having contraceptive and antiosteoporosis activity

Country Status (27)

Country Link
US (2) US6077873A (xx)
EP (1) EP0869132B1 (xx)
JP (1) JP4392066B2 (xx)
KR (1) KR19980071540A (xx)
CN (2) CN101092442A (xx)
AR (1) AR011680A1 (xx)
AT (1) ATE205217T1 (xx)
AU (1) AU723713B2 (xx)
BR (1) BR9800718B1 (xx)
CA (1) CA2229960C (xx)
CZ (1) CZ50598A3 (xx)
DE (1) DE69801539T2 (xx)
DK (1) DK0869132T3 (xx)
ES (1) ES2164400T3 (xx)
HK (1) HK1016188A1 (xx)
HU (1) HU223755B1 (xx)
ID (1) ID19947A (xx)
IL (1) IL123195A (xx)
NO (1) NO310724B1 (xx)
NZ (1) NZ329789A (xx)
PL (1) PL188079B1 (xx)
PT (1) PT869132E (xx)
RU (1) RU2182153C2 (xx)
SG (1) SG60203A1 (xx)
TR (1) TR199800282A1 (xx)
TW (1) TW403736B (xx)
ZA (1) ZA981344B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW403736B (en) * 1997-02-21 2000-09-01 Akzo Nobel Nv Steroid compounds having contraceptive and anti-osteoporosis activity
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
ATE246703T1 (de) * 1999-04-06 2003-08-15 Akzo Nobel Nv Oral wirksame 7-alpha-alkyl androgene
CO5271709A1 (es) 2000-01-12 2003-04-30 Pfizer Prod Inc Composiciones y procedimientos para el y tratamiento de afecciones que responden a estrogenos
TWI225068B (en) 2000-06-06 2004-12-11 Akzo Nobel Nv Anellated steroid compounds having contraceptive and anti-osteoporosis activity
JP2002241395A (ja) * 2001-02-16 2002-08-28 Taiho Yakuhin Kogyo Kk エストラ−４，６−ジエン−３，１７−ジオンの製造方法
US7250289B2 (en) 2002-11-20 2007-07-31 Affymetrix, Inc. Methods of genetic analysis of mouse
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
WO2008075930A1 (es) * 2006-12-20 2008-06-26 Landsteiner Scientific, S.A. De C.V. Composiciones de risedronato y vitamina d3
TW201109346A (en) * 2009-06-10 2011-03-16 Organon Nv Substituted 16,17-annellated steroid compounds for use in women's healthcare
US8367648B2 (en) 2009-06-10 2013-02-05 Msd Oss B.V. Substituted 16,17-annellated steroid compounds for use in womens healthcare

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0411733B1 (de) * 1989-08-04 1998-10-21 Schering Aktiengesellschaft 11 Beta-Aryl-gona-4,9-dien-3-one
ES2053091T3 (es) * 1989-08-04 1994-07-16 Schering Ag 16alfa,17beta-metilen-estra-4,9-dien-3-onas sustituidas en 11beta.
US5407928A (en) * 1990-08-15 1995-04-18 Schering Aktiengesellschaft 11β-aryl-gona-4,9-dien-3-ones
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints
TW403736B (en) * 1997-02-21 2000-09-01 Akzo Nobel Nv Steroid compounds having contraceptive and anti-osteoporosis activity

Also Published As

Publication number Publication date
BR9800718B1 (pt) 2009-08-11
TW403736B (en) 2000-09-01
HUP9800373A3 (en) 1999-06-28
KR19980071540A (ko) 1998-10-26
US6313180B1 (en) 2001-11-06
PL188079B1 (pl) 2004-12-31
ZA981344B (en) 1998-08-27
MX9801428A (es) 1998-12-31
JPH10273499A (ja) 1998-10-13
TR199800282A1 (xx) 1998-09-21
EP0869132A1 (en) 1998-10-07
US6077873A (en) 2000-06-20
EP0869132B1 (en) 2001-09-05
ATE205217T1 (de) 2001-09-15
CA2229960C (en) 2007-12-18
NO980737D0 (no) 1998-02-20
JP4392066B2 (ja) 2009-12-24
CN101092442A (zh) 2007-12-26
IL123195A (en) 2002-11-10
CA2229960A1 (en) 1998-08-21
HU223755B1 (hu) 2005-01-28
NZ329789A (en) 1999-09-29
NO980737L (no) 1998-08-24
CN1197076A (zh) 1998-10-28
DE69801539T2 (de) 2002-04-18
SG60203A1 (en) 1999-02-22
AU5541298A (en) 1998-08-27
PT869132E (pt) 2002-01-30
HU9800373D0 (en) 1998-04-28
NO310724B1 (no) 2001-08-20
DK0869132T3 (da) 2002-01-07
HUP9800373A2 (hu) 1998-11-30
IL123195A0 (en) 1998-09-24
ID19947A (id) 1998-08-27
DE69801539D1 (de) 2001-10-11
ES2164400T3 (es) 2002-02-16
PL324939A1 (en) 1998-08-31
BR9800718A (pt) 1999-06-29
CN100522984C (zh) 2009-08-05
RU2182153C2 (ru) 2002-05-10
AR011680A1 (es) 2000-08-30
AU723713B2 (en) 2000-09-07
CZ50598A3 (cs) 1998-09-16

Similar Documents

Publication Publication Date Title
EP1037635A4 (en) CONNECTIONS AROUND METHODS
IL138871A0 (en) Flushable diaper and method
EP0760128A4 (en) APPLICATION-SPECIFIC PROCESSOR AND METHOD FOR DESIGNING THE SAME
HU9900145D0 (en) Preparation of sterol and stanolesters
PL340623A1 (en) Oral contraceptive agents containing antistrogen and progestin
HU9702242D0 (en) Inozitol-glykanes of inzulin-like activity
PL341709A1 (en) Structural combination of rubber and metal
HK1016188A1 (en) Steroid compounds having contraceptive and antiosteoporosis activity
GB9702354D0 (en) Compounds and their use
EP0815116A4 (en) INHIBITING AND MODULATING THE ACTIVITY OF THE GONADOTROPIN RELEASE HORMONE RECEPTOR
GB2342182B (en) Ophthalmoscope and attachment therefor
HUP9800146A3 (en) Thalidomide-derivatives and use of them
PL328334A1 (en) Preparation and application thereof
HUP0101191A3 (en) Deprotection and recrystallization processes
EP0754701A4 (en) NEW PROGESTERONE COMPOUND AND ITS USE
EP0998578A4 (en) SEL-10 AND USES OF SEL-10
PL341293A1 (en) Beta-lypothropin and application thereof
AU135502S (en) Condom
HUP0102704A3 (en) Meiosis regulating steroid compounds and use thereof
SG44332A1 (en) Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas
ZA988065B (en) Pyrimidin-2-oxy-4-one and pyrimidin-2-oxy-4-thione derivatives
GB9722877D0 (en) Oestrogenic and phyto-oestrogenic compounds
GB9703517D0 (en) Steroid treatment
IL113766A0 (en) Metabolite and derivatives
GB9720258D0 (en) Extravise and Inavise

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20050218